Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
Q&A
Restoring Integrity: MiMedx CFO Pete Carlson
CFO Carlson helps biologics company MiMedx recover from an episode of revenue recognition fraud.
By
Vincent Ryan
| June 30, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Biosimilar
Risk & Compliance
How to Rein In the Soaring Costs of Specialty Drugs
The 420-employer National Business Group on Health recommends public-policy changes relating to the proliferating category of specialty drugs.
By
David McCann
| January 30, 2017
Read More
